Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Alexis Parcells

Plastic Surgery Spring Lake, NJ Medical Doctor

NPI 1659662179 CMS profile 4790917

309 Morris Ave Ste J, Spring Lake, NJ 07762

Open in the dashboard

General payments

$4,294

88 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Alexis Parcells of Spring Lake, NJ is reported in the CMS Open Payments database as having received $4,294 across 88 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 68th percentile of Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $714 14
2024 General $770 17
2023 General $1,428 18
2022 General $708 17
2021 General $350 11
2020 General $56 2
2019 General $268 9

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Alexis Parcells
  • Plastic Surgery median
  • Middle half of Plastic Surgery
  • National median

In program year 2025, general payments to Alexis Parcells were reported at $714. Among 3,701 Plastic Surgery profiles paid that year, the median was $379 and the middle half received between $138 and $1,100.

Show as a table
Year Alexis Parcells Plastic Surgery median Middle half National median
2019 $268 $371 $122–$1,483 $163
2020 $56 $158 $52–$438 $114
2021 $350 $249 $87–$752 $132
2022 $708 $274 $102–$793 $149
2023 $1,428 $299 $113–$891 $160
2024 $770 $361 $124–$1,062 $164
2025 $714 $379 $138–$1,100 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Mentor Worldwide LLC $2,030 43 payments
  2. Medical Device Business Services, Inc. $591 5 payments
  3. Merz North America, Inc. $344 4 payments
  4. Allergan Inc. $323 10 payments
  5. AbbVie, Inc. $304 7 payments
  6. Revance Therapeutics, Inc. $228 3 payments
  7. RTI Surgical, Inc $191 2 payments
  8. Tepha Inc $47 2 payments
  9. Davol Inc. $41 2 payments
  10. Integra LifeSciences Corporation $39 2 payments
  11. Other $156 8 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,947 87 payments
  2. Travel and Lodging $347 1 payment
Products named General payments · program years 2019–2025
  1. MENTOR MemoryGel Resterilizable Gel Sizer $1,798 38 payments
  2. Xeomin $344 4 payments
  3. DAXXIFY $228 3 payments
  4. CORTIVA ALLOGRAFT DERMIS $191 2 payments
  5. ARTOURA Breast Tissue Expander $180 3 payments
  6. BOTOX COSMETIC $171 3 payments
  7. MENTOR CPX 2 Breast Tissue Expander $132 1 payment
  8. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastic Surgery $119 3 payments
  9. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastics $89 3 payments
  10. GalaFLEX $47 2 payments
  11. Other $424 21 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

88 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic Surgery in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record